In vivo T cell depletion with myeloablative regimens on outcomes after cord blood transplantation for acute lymphoblastic leukemia in children Journal Article
| Authors: | Ponce, D. M.; Eapen, M.; Sparapani, R.; O'Brien, T. A.; Chan, K. W.; Chen, J.; Craddock, J.; Schultz, K. R.; Wagner, J. E.; Perales, M. A.; Barker, J. N. |
| Article Title: | In vivo T cell depletion with myeloablative regimens on outcomes after cord blood transplantation for acute lymphoblastic leukemia in children |
| Abstract: | The inclusion of antithymocyte globulin (ATG) in cord blood transplantation is controversial. We evaluated outcomes according to ATG inclusion in 297 children and adolescents with acute lymphoblastic leukemia (ALL) who received myeloablative total body irradiation-based conditioning and either single-unit (74%) or double-unit (26%) grafts. Ninety-two patients (31%) received ATG and 205 (69%) did not. ATG recipients were more likely to be cytomegalovirus seronegative. The incidences of day 100 grades II to IV acute graft-versus-host disease (GVHD; 30% versus 54%, P = .0002) and chronic GVHD (22% versus 43%, P = .0008) were lower with ATG compared with non-ATG regimens. However, day 100 grades III to IV acute GVHD was comparable (11% versus 17%, P = .15). The 3-year incidences of transplant-related mortality (16% versus 17%, P = .98), relapse (17% versus 27%, P = .12), and leukemia-free survival (66% versus 55%, P = .23) in ATG and non-ATG recipients were similar. There were no differences in viral reactivation between treatment groups (60% versus 58%, P = .83). Therefore, the data suggest that incorporation of ATG with myeloablative conditioning regimens may be useful in reducing the risk of acute and chronic GVHD without any deleterious effect on transplant-related mortality, relapse, or leukemia-free survival in children and adolescents with ALL. © 2015 American Society for Blood and Marrow Transplantation. |
| Keywords: | adolescent; adult; child; controlled study; human cell; major clinical study; overall survival; disease free survival; neutrophil count; thrombocyte; in vivo study; acute lymphoblastic leukemia; acute graft versus host disease; cord blood stem cell transplantation; graft failure; hla matching; myeloablative conditioning; whole body radiation; neutrophil; multicenter study; thrombocyte count; virus infection; t cell depletion; immunosuppressive treatment; hla a antigen; hla b antigen; donor selection; leukemia relapse; mycosis; graft recipient; thymocyte antibody; virus reactivation; human; male; female; article; in vivo t cell depletion; graft pancreatitis |
| Journal Title: | Biology of Blood and Marrow Transplantation |
| Volume: | 21 |
| Issue: | 12 |
| ISSN: | 1083-8791 |
| Publisher: | Elsevier Inc. |
| Date Published: | 2015-12-01 |
| Start Page: | 2173 |
| End Page: | 2179 |
| Language: | English |
| DOI: | 10.1016/j.bbmt.2015.08.022 |
| PROVIDER: | scopus |
| PMCID: | PMC4639413 |
| PUBMED: | 26327630 |
| DOI/URL: | |
| Notes: | Export Date: 2 December 2015 -- Source: Scopus |
Altmetric
Citation Impact
BMJ Impact Analytics
Related MSK Work